Arsanis, Inc. (97) | Business Operations (7)

Browse by Subcategory

Services Agreements (6)
Settlement Agreements (1)

Recent Contracts

Amendment No. 2 to Master Services Agreement, dated February (Filed With SEC on March 19, 2021)
Settlement Agreement, dated as of March 8, 2019, by and among X4 Pharmaceuticals, Inc. (formerly Arsanis, Inc.), Artemis AC Corp., X4 Therapeutics, Inc. (formerly X4... (Filed With SEC on April 11, 2019)
Master Services Agreement, dated September 10, 2015, by and between X4 Pharmaceuticals Inc. and Mayne Pharma Inc. (formerly known as Metrics, Inc.) (Filed With SEC on March 12, 2020)
Amendment No. 1 to Master Services Agreement, dated August 25, 2017, by and between X4 Pharmaceuticals Inc. and Mayne Pharma Inc. (formerly known as Metrics, Inc.) (Filed With SEC on March 12, 2020)
Amendment No. 2 to Master Services Agreement, dated February 28, 2020, by and between X4 Pharmaceuticals Inc. and Mayne Pharma Inc (Filed With SEC on March 12, 2020)
Master Services Agreement, dated February 19, 2016, by and between X4 Pharmaceuticals Inc. and Aptuit (Oxford) Limited (Filed With SEC on March 12, 2020)
Amendment No. 1 to Master Services Agreement, dated February 19, 2016, by and between X4 Pharmaceuticals Inc. and Aptuit (Oxford) Limited (Filed With SEC on March 12, 2020)